HealthLynked (HLYK) Cash from Financing Activities (2016 - 2026)

HealthLynked has disclosed Cash from Financing Activities across 11 years of filings, most recently posting $208813.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities fell 44.84% year-over-year to $208813.0; the TTM figure through Mar 2026 stood at $1.4 million (down 47.84% YoY), while the FY2025 annual figure was $1.5 million, down 46.58% from the prior year.
• Cash from Financing Activities declined to $208813.0 in Q1 2026, from $320655.0 in the prior quarter.
• Over the last five years, Cash from Financing Activities for HLYK reached as high as $1.2 million in Q3 2022 and fell as low as $23175.0 in Q3 2023.
• The 5-year median for Cash from Financing Activities is $379885.0 (2024), against an average of $476791.4.
• Annual changes were most pronounced in 2022 — Cash from Financing Activities surged 6646.84% — and 2023, when it slumped 98.01%.
• A 5-year view of Cash from Financing Activities shows it stood at $504107.0 in 2022, then plunged by 59.94% to $201957.0 in 2023, then surged by 88.1% to $379885.0 in 2024, then fell by 15.59% to $320655.0 in 2025, then slumped by 34.88% to $208813.0 in 2026.
• According to Business Quant data, Cash from Financing Activities over the past three periods registered $208813.0, $320655.0, and $435001.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.